David Olsen

David Olsen is an experienced professional in the field of pharmacology and toxicology, currently serving as the Director of Cell Line Development at FibroGen, Inc. since November 1999. Prior to this role, David Olsen was a Principal Scientist at Cohesion Technologies from June 1997 to October 1999. David Olsen holds a Doctor of Philosophy (Ph.D.) in Pharmacology and Toxicology from the University of Rhode Island, obtained between 1980 and 1985, and a Bachelor's Degree in Biology from Boston College, earned from 1976 to 1980.